$3.04
Value $1.2B
CRON and FCX stock compared: price, dividend, valuation and results, from SEC filings.
$3.04
Value $1.2B
$45.99
Value $66.1B
Cronos (CRON) has a market value of $1.2B and Freeport-McMoRan (FCX) $66.1B. Over the last year, with dividends, CRON moved +28.8% and FCX +12.5%. The P/E is 19.9 for CRON and 19.2 for FCX. Dividend yield: CRON none, FCX 1.30%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CRON$1.2B
FCX$66.1B
FCX is 57 times CRON
Revenue, 12 months
CRON$206M
FCX$26.4B
FCX is 128 times CRON
Net income, 12 months
CRON$58M
FCX$3.4B
FCX is 60 times CRON
Operating margin
CRON3.4%
FCX27.6%
24.2 points apart
ROIC
CRON0.5%
FCX18.0%
17.5 points apart
P/E
CRON19.9
FCX19.2
About the same
Dividend yield
CRON0.0%
FCX1.3%
1.3 points apart
5-year return
CRON-38.3%
FCX+28.8%
67.1 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CRON-38.3%
FCX+28.8%
| Period | CRONWith dividends | FCXWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | +28.8%Price +28.8% | +12.5%Price +11.5% |
| 3 years since November 20, 2023 | +45.5%+13.3% a yearPrice +45.5% | +30.3%+9.2% a yearPrice +25.5% |
| 5 years since November 19, 2021 | -38.3%-9.2% a yearPrice -38.3% | +28.8%+5.2% a yearPrice +20.1% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CRONCronosFCXFreeport-McMoRan
| Price | $3.04 | $45.99 |
|---|---|---|
| Market value | $1.2B | $66.1B |
| Enterprise value (EV) | $411M | $71.2B |
| P/E | 19.9 | 19.2 |
| P/E, 5-year median | – | – |
| P/B | 1.1 | 3.2 |
| EV/EBIT | 57.9 | 9.7 |
| Free cash flow yield | 5.7% | 2.9% |
| Revenue, 12 months | $206M | $26.4B |
|---|---|---|
| Net income, 12 months | $58M | $3.4B |
| Free cash flow, 12 months | $65M | $1.9B |
| Earnings per share, 12 months | $0.17 | $2.40 |
| Revenue growth, year on year | 24.6% | 1.8% |
| Revenue growth a year, past | +25.7%over 5 years | +12.8%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 46.6% | 28.0% |
|---|---|---|
| Operating margin | 3.4% | 27.6% |
| Net margin | 28.0% | 13.0% |
| ROIC | 0.5% | 18.0% |
| ROE | 5.4% | 17.5% |
| Cash | $741M | $4.3B |
|---|---|---|
| Total debt | $1.2M | $10.4B |
| Net debt / EBITDA | -34.7 | 0.5 |
| Interest cover | – | – |
| Dividend yield | – | 1.3% |
|---|---|---|
| Dividend per share, 12 months | – | $0.60 |
| Dividend growth a year, past | – | – |
| Buyback yield | 0.9% | 0.2% |
| Shareholder yield | 0.9% | 1.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Freeport-McMoRan ($66.1B) is about 57.4 times Cronos ($1.2B), at today's prices.
Since November 19, 2021, CRON's price moved -38.3% and FCX's +20.1%. With dividends: CRON -38.3% (-9.2% a year), FCX +28.8% (+5.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Cronos and 1.30% for Freeport-McMoRan. Over the last twelve months they paid – and $0.60 per share.
At today's price, the P/E is 19.9 for CRON and 19.2 for FCX. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 28.0% for Cronos and 13.0% for Freeport-McMoRan, and the operating margin 3.4% and 27.6%. Revenue was $206M and $26.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.